Company Filing History:
1 out of 6 
1 out of 377 
Years Active: 2007
Title: Matthias Majetschak: Innovator in Immune System Research
Introduction
Matthias Majetschak is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of immunology, particularly in the treatment and prevention of harmful immune system activation. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Majetschak holds a patent titled "Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system." This patent focuses on compositions and methods for suppressing the immune system of a mammal using ubiquitin and its derivatives and analogs. This innovative approach has the potential to advance therapeutic strategies in immunology.
Career Highlights
Throughout his career, Matthias Majetschak has been associated with prestigious institutions such as the University of Heidelberg and the University of Miami. His work at these universities has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.
Collaborations
One of his notable collaborators is Kenneth G Proctor. Their partnership has likely fostered advancements in research and development within the realm of immune system modulation.
Conclusion
Matthias Majetschak's contributions to immunology through his patent and collaborations highlight the critical role of inventors in advancing medical science. His innovative approaches continue to pave the way for future research and therapeutic developments.